The investigators plan to use amoxicillin in capsule form, prepared by a pharmacist, for
antibiotic prophylaxis to decrease the failure rate of mini-screw implants temporarily placed
in the palate of patients involved in Phase II orthodontics treatments. The mini-screws will
be 8 mm long 1.7 mm diameter titanium screws manufactured by Forestadent and are commercially
available and currently widely used in orthodontic treatment in both private practice and
educational settings. Since antibiotic prophylaxis is considered the standard of care with
traditional dental implants, the investigators believe that such prophylaxis will decrease
the failure rate of orthodontic mini-screw implants also.